Simulations Plus, University of Health Sciences and Pharmacy in St. Louis secures new grant from USFDA (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) through a joint proposal with the St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis, it has been awarded a new funded cooperative agreement from the USFDA.

Both to establish novel in vitro/in silico models for the oral cavity route of administration in GastroPlus® to accelerate pharmaceutical research and regulatory assessment of innovative and generic drug products delivered intraorally.

Press Release

Source Article

Recommended Articles